The safety committee of the European Medicines Agency (EMA) will again study the medication, semaglutide, out of concerns ...

Perfluorohexyloctane and lotilaner ophthalmic solution, 2 ocular surface disease drugs, have changed the DED and DB treatment paradigms.

Stand-alone canaloplasty and trabeculotomy with the Omni surgical system showed positive real-world outcomes in reducing IOP ...

Patients with diabetic DED can experience inflammatory biomarker reductions and sign and symptom improvements with topical insulin.

Extended preoperative use of topical glaucoma medications with preservatives may negatively affect long-term trabeculectomy ...